Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Honey and Nigella Sativa in the Management of COVID-19; A Randomized Controlled, Open-label, Add-on Trial in Pakistan

NCT04347382 is registered in ClinicalTrials.gov with Sohaib Ashraf as lead sponsor.

NCT NCT04347382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04347382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Honey and Nigella Sativa in the Management of COVID-19; A Randomized Controlled, Open-label, Add-on Trial in Pakistan
Lead sponsor
Sohaib Ashraf
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2020
Completion date
August 30, 2020
Enrollment
313 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, sars-cov2